Skip to main content

Miller Derek's Form 4 filing

Amgen Inc (AMGN) · filed Feb 20, 2025

Accession no.
0001127602-25-006112
Filed
Feb 20, 2025
Trade date
Feb 18-19, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $593.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Miller DerekCIK 0001917312Officer (SVP, Human Resources)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 18, 2025Common StockSSaleDisposed−500$292.56−$146,2808,544Direct
Feb 19, 2025Common StockMOption exerciseAcquired+1,524$156.35+$238,277.410,068Direct
Feb 19, 2025Common StockSSaleDisposed−1,524$293.74−$447,659.768,544Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 19, 2025Common StockMOption exerciseDisposed−1,524$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)